Login / Signup

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms.

Nicolas HoertelMarina Sánchez-RicoCéline CougouleErich GulbinsKornhuber JohannesAlexander CarpinteiroKatrin Anne BeckerAngela M ReiersenEric J LenzeDavid SeftelCédric LemogneFrédéric Limosin
Published in: Molecular psychiatry (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • major depressive disorder
  • signaling pathway
  • human health
  • respiratory syndrome coronavirus
  • bipolar disorder
  • drug discovery